Inventor
LIN CHIA YANG
US49 patents
⚠️ This page may combine multiple inventors who share the name “LIN CHIA YANG”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
REGENERON PHARMA
21 patentsUS11725034B2Aug 15, 2023
IL2 agonists and methods of use thereof
REGENERON PHARMA4 citations84
US12180272B2Dec 31, 2024
Antigen binding molecule formats
REGENERON PHARMA2 citations72
US12077603B2Sep 3, 2024
Multispecific antigen-binding molecules for cell targeting and uses thereof
REGENERON PHARMA3 citations72
US12065508B2Aug 20, 2024
Multispecific antigen-binding molecules for cell targeting and uses thereof
REGENERON PHARMA3 citations72
US11952430B2Apr 9, 2024
Multispecific antigen-binding molecules for cell targeting and uses thereof
REGENERON PHARMA3 citations72
US11708407B2Jul 25, 2023
Antigen binding molecule formats
REGENERON PHARMA2 citations72
US12091440B2Sep 17, 2024
IL2 and peptide-MHC complex fusion proteins and methods of use thereof
REGENERON PHARMA1 citations71
US12415856B2Sep 16, 2025
EGFR x CD28 multispecific antibodies
REGENERON PHARMA0 citations62
US12391753B2Aug 19, 2025
Antigen binding molecule formats
REGENERON PHARMA0 citations62
US12331109B2Jun 17, 2025
Antigen binding molecule formats
REGENERON PHARMA0 citations62
US11965020B2Apr 23, 2024
Antigen binding molecule formats
REGENERON PHARMA0 citations62
US11912767B2Feb 27, 2024
EGFR × CD28 multispecific antibodies
REGENERON PHARMA1 citations62
US12522638B2Jan 13, 2026
IL12 receptor agonists and methods of use thereof
REGENERON PHARMA0 citations61
US12459991B2Nov 4, 2025
Compositions and methods for using bispecific antibodies to bind complement and a target antigen
REGENERON PHARMA0 citations61
US12319724B2Jun 3, 2025
IL2 agonists and methods of use thereof
REGENERON PHARMA0 citations61
US12274747B2Apr 15, 2025
Compositions and methods for treating cytokine release syndrome
REGENERON PHARMA0 citations61
US12240907B2Mar 4, 2025
N-terminal scFv multispecific binding molecules
REGENERON PHARMA0 citations61
US12240908B2Mar 4, 2025
N-terminal scFv multispecific binding molecules
REGENERON PHARMA0 citations61
US12215131B2Feb 4, 2025
IgG Fc-IL2-Rα-IL2 fusions and methods of use thereof
REGENERON PHARMA0 citations61
US12559576B2Feb 24, 2026
CD20-PD1 binding molecules and methods of use thereof
REGENERON PHARMA0 citations59
US12528851B2Jan 20, 2026
IL2-based therapeutics and methods of use thereof
REGENERON PHARMA0 citations50
APPLE INC
19 patentsUSD945464SMar 8, 2022
Display screen or portion thereof with graphical user interface
APPLE INC12 citations92
US11570129B2Jan 31, 2023
User interfaces for messaging conversations
APPLE INC4 citations86
USD973703SDec 27, 2022
Display or portion thereof with graphical user interface
APPLE INC8 citations85
USD1059397SJan 28, 2025
Display screen or portion thereof with animated graphical user interface
APPLE INC6 citations84
USD1035691SJul 16, 2024
Display screen or portion thereof with animated graphical user interface
APPLE INC5 citations84
USD978900SFeb 21, 2023
Display screen or portion thereof with graphical user interface
APPLE INC5 citations84
USD1087151SAug 5, 2025
Display screen or portion thereof with graphical user interface
APPLE INC2 citations75
US11888796B2Jan 30, 2024
User interfaces for messaging conversations
APPLE INC2 citations73
US11671387B2Jun 6, 2023
User interfaces for messaging conversations
APPLE INC1 citations73
USD1096803SOct 7, 2025
Display screen or portion thereof with graphical user interface
APPLE INC0 citations63
USD1121664SApr 7, 2026
Computer display system or portion thereof showing a graphical user interface having a three dimensional appearance
APPLE INC0 citations62
USD1119993SMar 24, 2026
Display screen or portion thereof with graphical user interface
APPLE INC0 citations62
USD1112325SFeb 10, 2026
Display screen or portion thereof with animated graphical user interface
APPLE INC0 citations62
US12255857B2Mar 18, 2025
User interfaces for messaging conversations
APPLE INC0 citations62
USD1114828SFeb 24, 2026
Display screen or portion thereof with animated graphical user interface
APPLE INC0 citations61
US11875016B2Jan 16, 2024
Devices, methods, and graphical user interfaces for displaying media items shared from distinct applications
APPLE INC1 citations61
US11670144B2Jun 6, 2023
User interfaces for indicating distance
APPLE INC1 citations55
US12506953B2Dec 23, 2025
Device, methods, and graphical user interfaces for capturing and displaying media
APPLE INC0 citations51
US12530107B2Jan 20, 2026
Devices, methods, and graphical user interfaces for displaying media items shared from distinct applications
APPLE INC0 citations50
RINAT NEUROSCIENCE CORP
5 patentsUS9248189B2Feb 2, 2016
Anti-glucagon receptor antibodies and pharmaceutical compositions thereof
RINAT NEUROSCIENCE CORP5 citations70
US8637273B2Jan 28, 2014
Nucleic acid encoding IL-7 receptor alpha antibody
RINAT NEUROSCIENCE CORP1 citations60
US10059772B2Aug 28, 2018
Antagonist anti-IL-7 receptor antibodies and methods
RINAT NEUROSCIENCE CORP0 citations49
US9346885B2May 24, 2016
Method of treating type 1 diabetes with antagonist IL-7 receptor antibodies
RINAT NEUROSCIENCE CORP0 citations49
US9249224B2Feb 2, 2016
Human growth hormone receptor antagonist antibodies and methods of use thereof
RINAT NEUROSCIENCE CORP0 citations46